JPH0356739B2 - - Google Patents
Info
- Publication number
- JPH0356739B2 JPH0356739B2 JP58062239A JP6223983A JPH0356739B2 JP H0356739 B2 JPH0356739 B2 JP H0356739B2 JP 58062239 A JP58062239 A JP 58062239A JP 6223983 A JP6223983 A JP 6223983A JP H0356739 B2 JPH0356739 B2 JP H0356739B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- resin composition
- blood
- styrene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004369 blood Anatomy 0.000 claims description 42
- 239000008280 blood Substances 0.000 claims description 42
- 239000011342 resin composition Substances 0.000 claims description 30
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 22
- 230000035699 permeability Effects 0.000 claims description 22
- 238000003860 storage Methods 0.000 claims description 20
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 19
- 229920003048 styrene butadiene rubber Polymers 0.000 claims description 19
- 229920000578 graft copolymer Polymers 0.000 claims description 15
- 239000003381 stabilizer Substances 0.000 claims description 12
- 239000001569 carbon dioxide Substances 0.000 claims description 11
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 11
- 150000004820 halides Chemical class 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 10
- 239000004014 plasticizer Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000012424 soybean oil Nutrition 0.000 description 6
- 239000003549 soybean oil Substances 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 239000004800 polyvinyl chloride Substances 0.000 description 5
- 229920000915 polyvinyl chloride Polymers 0.000 description 5
- 229920003314 Elvaloy® Polymers 0.000 description 4
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- -1 phthalate ester Chemical class 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229920001038 ethylene copolymer Polymers 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- HNNQYHFROJDYHQ-UHFFFAOYSA-N 3-(4-ethylcyclohexyl)propanoic acid 3-(3-ethylcyclopentyl)propanoic acid Chemical compound CCC1CCC(CCC(O)=O)C1.CCC1CCC(CCC(O)=O)CC1 HNNQYHFROJDYHQ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920013623 Solprene Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- YCZJVRCZIPDYHH-UHFFFAOYSA-N ditridecyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCCCC YCZJVRCZIPDYHH-UHFFFAOYSA-N 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 239000003634 thrombocyte concentrate Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Graft Or Block Polymers (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
çºæã®èæ¯
æè¡åé
æ¬çºæã¯ãæ°èŠãªè¡æ¶²ä¿å容åšçšæš¹èçµæç©ã«
é¢ãããã®ã§ããã詳ããè¿°ã¹ããšãæè»æ§ãã
ã³èç±æ§ãè¯å¥œã§ãã€é«åšæ³¢èçãå¯èœã§ããã
ã«æ°äœééæ§ã®åªããè¡æ¶²ä¿å容åšçšå¡©åããã«
ç³»ã°ã©ããå
±éåäœçµæç©ã«é¢ãããã®ã§ããã
å
è¡æè¡
åšç¥ã®ããã«ãè¡æ¶²ã¯èªå·±é²åŸ¡äœçšãæããŠã
ããè¡æ¶²ãè¡ç®¡å
å£ä»¥å€ã®ç°çé¢ã«æ¥ãããšãç°
çé¢ãžã®è¡å°æ¿ã®ç²çãåéããã³è¡æŒ¿ã®ã²ã«
åãããªãã¡ãã€ããªã³æ¶æ©äœã®åœ¢æãèµ·ããã
åŸæ¥ã®è¡æ¶²ããã°ã¯ãè¡æ¶²äžã®è¡å°æ¿ãè¡æ¶²ãã
ã°ã®åºæã§ãããã©ã¹ããã¯çé¢ãžåéããæ¡è¡
åŸïŒæéåŸã«ã¯è¡å°æ¿åéèœãæ¡è¡æã®çŽ60ïŒ
ã«
äœäžããããã«24æéåŸã«ã¯çŽ40ïŒ
ã«ãŸã§äœäžã
ããäžæ¹ãçŸåšã®è¡å°æ¿è£œå€ã®æå¹å©çšã®ç¹ã
ããããé·æéã®è¡æ¶²ã®ä¿åãå¯èœãªãã©ã¹ãã
ã¯ãããªãä¿å容åšãããããè¡æ¶²é©åæ§ãæã
ããã©ã¹ããã¯ãããªãä¿å容åšããããã¯ãã®
å°ã®å»ççšå
·ã®éçºãæãŸããŠããã
ãã®ãããªãã©ã¹ããã¯è£œå®¹åšãŸãã¯ãã®ä»ã®
å»ççšå
·ãšããŠãçŸåšããã®å å·¥æ§ãæè»æ§ãé
ææ§ãäœæ°Žèžæ°ééæ§ãèç±æ§çã®è¯å¥œãã®æ
ã«ãè»è³ªå¡©åããã«æš¹è補ã®ãã®ãåºã䜿çšãã
ãŠããããããã®è»è³ªå¡©åããã«æš¹èã¯ãå¯å¡å€
ãšããŠãžâïŒâãšãã«ããã·ã«ãã¿ã¬ãŒãïŒä»¥
äžãDOPãšãããïŒçã®ãã¿ã«é
žãšã¹ãã«ã30ã
60ïŒ
å«ãŸããŠãããããããªããããã¿ã«é
žãšã¹
ãã«ã¯ç§»è¡æ§ã倧ããã®ã§ãåèšè»è³ªå¡©åããã«
æš¹èã§ãäŸãã°è¡æ¶²ä¿å容åšãäœã€ãå Žåã該ã
ã¿ã«é
žãšã¹ãã«ãè¡æŒ¿äžã«æº¶åºããããšãç¥ãã
ãŠããããã®ãããæ¿çž®è¡å°æ¿ãå«ãè¡æŒ¿ã«ãã¿
ã«é
žãšã¹ãã«ã溶ãåºããšãè¡å°æ¿ã®æ©èœã§ãã
åéèœã®äœäžããŸããããšããå ±åããªãããŠã
ãããæ¥æ¬èŒžè¡åŠçèª28ã282ïŒ1982ïŒãããŸããå
èšãã¿ã«é
žãšã¹ãã«ç³»å¯å¡å€ãå«æããè»è³ªå¡©å
ããã«æš¹èã¯ãæ°äœééæ§ãäžå
åã§ããããã
ãçšããè¡æ¶²ããã°ã®è¡å°æ¿ä¿åæ§ã瀺ãæå¹æ
éã¯éåžžïŒæéãšããçæéã§ãããªããããªã
ã¡ãè»è³ªå¡©åããã«æš¹èã¯çé
žã¬ã¹ã®ééä¿æ°ã
çŽ2.0Ã103mlã»mmïŒm2ã»atmã»dayçšåºŠã§ããã
ãããçšããè¡æ¶²ããã°ã«ãããŠæ¿çž®è¡å°æ¿è¡æŒ¿
ã®æå¹æéã¯ïŒæéã§ãã€ãããããããã®éé
ä¿æ°ã2.5Ã103ã9.0Ã103mlã»mmïŒm2ã»atmã»day
ãã奜ãŸããã¯3.0Ã103ã8.0Ã103mlmmïŒm2ã»
atmã»dayãšããããšã«ããè¡å°æ¿ã®ä¿åæ§ãé«
ããè¡å°æ¿ãæå¹ã«ä¿åããããšãã§ãããšãã
ãPHïŒä»¥äžã72æé以äžã«äºãç¶æã§ããã2.5
æªæºã§ãããšè¡å°æ¿ã®ä»£è¬ã«ããçããCO2æ¿åºŠ
ãé«ããªãPHãäœäžããè¡å°æ¿ã®ä¿åæ§ã®ç¹ã§é·
æéãæããªãããŸã9.0ããã倧ãããªããšã
è¡å°æ¿ã®ä»£è¬ã掻æ§åããéãã§è¡å°æ¿ã®æ©èœã
çæéã§æããããããå°ãäžèšééä¿æ°ã®ç¯å²
å
ãšããããšã«ããä»ã®è¡æ¶²çŽ°èã®ä¿åæ§ãé«ã
ãããšãã§ããããã®ãã該å¯å¡å€ã®é
åéãå€
ãããã°æ°äœééæ§ã¯åäžãããã該é
åéãå€
ãããã°éã«å®çšçãªæ©æ¢°ç匷床ã倱ãããŠããŸ
ãããããã€ãŠãè¡å°æ¿çã®è¡æ¶²çŽ°èã®é·æä¿å
ãå¯èœãšããæ°äœééæ§ãããªãã¡2.5Ã103ã9.0
Ã103mlã»mmïŒm2ã»atmã»dayãåŸãããšã¯å°é£ã§
ããã
äžæ¹ãé移è¡æ§ã®å¯å¡å€ãšããŠã¯ãããªãšã¹ã
ã«ç³»å¯å¡å€ãçšããããŠããããã®ããªãšã¹ãã«
ç³»å¯å¡å€ã¯ãäžè¬ã«èèªé
žãšã¹ãã«ãäž»ãããã®
ã§ãããããèæ°Žæ§ãèå æ°Žå解æ§çã«ãããŠã¯
ããšãã«åºãéªšæ Œãšãããã¿ã«é
žãšã¹ãã«ããã
å£ã€ãŠããããšã¯ããç¥ãããŠããã
ä»æ¹ãæ°äœééæ§ãæ¯èŒçè¯å¥œãªè¡æ¶²ããã¯çš
ææãšããŠã10ã40ééïŒ
ã®ããªãããã¬ã³ãšã
40ã85ééïŒ
ã®ç±å¯å¡æ§ãšã©ã¹ãããŒãšã®ãã¬ã³
ããããªãæš¹èçµæç©ãç¥ãããŠãããïŒç¹éæ
55â60464å·ïŒããã®ãããªããªãªã¬ãã€ã³ç³»æš¹è
ã¯æ¥çæ§ãæªãããã«ãäºæ¬¡å å·¥ã®éãé«åšæ³¢è
çãå°é£ã§ãããæ圢å å·¥æ³ãéå®ãããããŸ
ããè»è³ªããªå¡©åããã«ãçšããå Žåã®ãããªæ
è»æ§ã«æ¬ ããã
çºæã®ç®ç
ãããã€ãŠãæ¬çºæã®ç®çã¯ãæ°èŠãªè¡æ¶²ä¿å
容åšçšæš¹èçµæç©ãæäŸããããšã«ãããæ¬çºæ
ã®ä»ã®ç®çã¯ãæè»æ§ããã³èç±æ§ãè¯å¥œã§ãã€
é«åšæ³¢èçå¯èœã§ããã«æ°äœééæ§ã®åªããè¡æ¶²
ä¿å容åšçšå¡©åããã«ç³»ã°ã©ããå
±éåäœçµæç©
ãæäŸããããšã«ããã
ãããã®è«žç®çã¯ãã¹ãã¬ã³âãã¿ãžãšã³å
±é
åäœããã³ïŒãŸãã¯ãã®èªå°äœã«å¡©åããã«ãå
å¿ãããŠåŸãããå¡©åããã«éšå100éééšã«å¯Ÿ
ããŠã¹ãã¬ã³âãã¿ãžãšã³å
±éåäœããã³ïŒãŸã
ã¯ãã®èªå°äœéšåã20ã200éééšã®å²åã§ãã
ã°ã©ããå
±éåäœããã³å®å®å€ãããªãè¡æ¶²ä¿å
容åšçšæš¹èçµæç©ããéæãããããŸããæ¬çºæ
ã¯ãå¡©åããã«éšå100éééšã«å¯ŸããŠã¹ãã¬ã³
âãã¿ãžãšã³å
±éåäœããã³ïŒãŸãã¯ãã®èªå°äœ
éšåã30ã120éééšã§ããè¡æ¶²ä¿å容åšçšæš¹è
çµæç©ã§ãããããã«ãæ¬çºæã¯ãã¹ãã¬ã³âã
ã¿ãžãšã³å
±éåäœã®èªå°äœããã¹ãã¬ã³âãã¿ãž
ãšã³å
±éåäœã®ãšããã·åç©ãããã²ã³åç©ãŸã
ã¯ãã¬ã€ã³åç©ã§ããæš¹èçµæç©ã§ããããŸãã
æ¬çºæã¯ãã°ã©ããå
±éåäœ100éééšã«å¯ŸããŠ
å®å®å€ã0.05ãïŒéééšã§ããæš¹èçµæç©ã§ã
ãã
çºæã®å
·äœç説æ
æ¬çºæã«ãããŠäœ¿çšãããã°ã©ããå
±éåäœ
ã¯ãæ°èŠååç©ã§ãã€ãŠãã¹ãã¬ã³âãã¿ãžãšã³
å
±éåäœããã³ïŒãŸãã¯ãã®èªå°äœã«å¡©åããã«
ãåå¿ãããããšã«ããåŸããããã®ã§ããã該
ã°ã©ããå
±éåäœããã³ïŒãŸãã¯ãã®èªå°äœéšå
ã¯20ã200éééšã奜ãŸããã¯30ã120éééšã§ã
ããããã¯ã該å
±éåäœãªãããã®èªå°äœã20é
ééšæªæºã§ã¯ãã°ã©ããå
±éåäœã®æè»æ§ãäœ
ããäžæ¹ã200éééšãè¶ãããšãæ©æ¢°ç匷床ã
äœäžããã€é«åšæ³¢èçãå°é£ãšãªãããã§ããã
ãã®ãããªã°ã©ããå
±éåäœã¯ãäŸãã°å¡©åã
ãã«ããã³ã¹ãã¬ã³âãã¿ãžãšã³å
±éåäœãªãã
ãã®èªå°äœãåèšå²åãšãªãããã«åå¿åšã«ä»èŸŒ
ã¿ãã©ãžã«ã«éå觊åªã®ååšäžã«å¡©åããã«ãæž
æ¿éåããããšã«ããåŸãããããã®ããã«ããŠ
åŸãããã°ã©ããå
±éåäœã¯ãå¿
èŠã«ããæ°Žãã¢
ã«ã³ãŒã«ã«ããæŽæµç²Ÿè£œãããã
䜿çšãããã¹ãã¬ã³âãã¿ãžãšã³å
±éåäœã¯ã
ã¹ãã¬ã³å¯Ÿãããžãšã³ã®ã¢ã«æ¯ãïŒïŒïŒãïŒïŒ
10ã奜ãŸããã¯ïŒïŒïŒãïŒïŒïŒã®ã©ã³ãã ãªãã
ãããã¯å
±éåäœã§ããã®ååéã¯50000ã
200000ã奜ãŸããã¯70000ã190000ã§ãããå®äŸ
ãæãããšãäŸãã°ã«ãªãã¬ãã¯ã¹TRâ110ïŒã·
ãšã«ååŠè£œïŒãã«ãªãã¬ãã¯ã¹TRâ1107ïŒã·ãšã«
ååŠè£œïŒããœã«ãã¬ã³ïŒæåæ補ããã€ãªããã¹
補ïŒãã¿ããã¬ã³ïŒæåæ補ïŒãã¯ã¬ã€ãã³ïŒ§ïŒã·
ãšã«ååŠè£œïŒçãããããŸãããã®èªå°äœãšããŠ
ã¯ãåèšã¹ãã¬ã³âãã¿ãžãšã³å
±éåäœã®ãšãã
ã·åç©ãããã²ã³åç©ããã¬ã€ã³åç©çãããã
æ¬çºæã«ããæš¹èçµæç©äžã«é
åãããå®å®å€
ãšããŠã¯ãã«ã«ã·ãŠã ãäºéçã®éå±ãšã¹ãã¢ãª
ã³é
žãã©ãŠãªã³é
žããªã·ããŒã«é
žããããã³é
žã
ïŒâãšãã«ãããœã€ã³é
žçã®èèªé
žãšã®éå±ãã€
ããçãããããããã¯ïŒçš®é¡ãŸãã¯ïŒçš®é¡ä»¥äž
ããåèšã°ã©ããå
±éåäœ100éééšã«å¯ŸããŠ
0.05ãïŒéééšã奜ãŸããã¯0.1ãïŒéééšé
å
ãããããŸããåèšå®å®å€ã®ä»ã«ãå®å®å©å€ãšã
ãŠãšããã·å倧è±æ²¹ããšããã·åã¢ããæ²¹çã®ãš
ããã·åæ€ç©æ²¹ããåèšã°ã©ããå
±éåäœ100é
ééšã«å¯ŸããŠ30éééšä»¥äžã奜ãŸããã¯ïŒã20é
ééšé
åããããšãã§ããã
ããã«ãæ¬çºæã®æš¹èçµæç©ã«ãããŠã¯ãé«å
åå¯å¡å€ãé
åããããšãã§ãããé«ååå¯å¡å€
ãšããŠã¯ããšãã¬ã³å
±éåäœãäŸãã°ãšãã¬ã³â
é
¢é
žããã«âã±ãã³å
±éåäœãäŸãã°ãšã«ããã€
ïŒElvaloyïŒ742.E.I.du Pont de Nemours ïŒ
Co.補ããããªãšã¹ãã«ãäŸãã°ããªã«ããã©ã¯ã
ã³âïœâïŒããªã¹ãã¬ã³ïŒãããªÎµâã«ããã©ã¯ã
ã³ãäŸãã°PCL 300ãPCL 700ïŒä»¥äžãUnion
Carbide瀟補ïŒãããªãšã¹ãã«ãäŸãã°Nuoplaz
6187ïŒTenneco Chemicals瀟補ïŒãParaplex â
25ãParaplex â54ïŒä»¥äžRohm ïŒ Haas瀟
補ïŒãAdmex 761ïŒAshland Chemicals瀟補ïŒçã
çãããããããã®ãã¡ãç¹ã«åèšãšãã¬ã³å
±é
åäœïŒäŸãã°Elvaloy 742ïŒãåªããå¹æãçºæ®
ããããããã®é«ååå¯å¡å€ã¯ãåèšã°ã©ããå
±
éåäœ100éééšã«å¯ŸããŠ150éééšä»¥äžã奜ãŸã
ãã¯10ã90éééšé
åãããããŸããæ»å€ããã®
ä»ã®æ·»å å€ãæ¯æ§ã瀺ããªãç¯å²ã§äœ¿çšããããš
ãã§ããã
æ¬çºæã«ããæš¹èçµæç©ã¯ãéåžžäžè¬ã«çšãã
ããŠãããã¬ã¹æ圢æ©ãæŒåºæ圢æ©ãå°åºæ圢
æ©ããããŒæ圢æ©ãã€ã³ãã¬ãŒã·ãšã³æ圢æ©ãã«
ã¬ã³ããŒæ圢æ©çã§æ圢å å·¥ããããšãå¯èœã§ã
ãããããã®æ圢ç©ã¯ãé«åšæ³¢èçæ©çãçšãçµ
ç«å å·¥ããããšã«ããè¡æ¶²ä¿å容åšãåŸãããã
ãã®ããã«ããŠåŸãããæš¹èçµæç©ã¯éææ§ã
è¯å¥œã§æè»æ§ã«å¯ã¿ãèç±æ§ãè¯å¥œã§é«åšæ³¢èç
ãå¯èœã§ããã€çé
žã¬ã¹ééä¿æ°ã2.5Ã103ã9.0
Ã103mlã»mmïŒm2ã»atmã»dayïŒ30âïŒå¥œãŸããã¯
3.0Ã103ã8.0Ã103mlã»mmïŒm2ã»atmã»dayïŒ30âïŒ
ã§ããã
ã€ãã«ãå³é¢ãåç
§ããªãããæ¬çºæã®æš¹èçµ
æç©ã«ããæ¡è¡ããã°ã補é ããå Žåã«ã€ããŠèª¬
æãããããªãã¡ãå³è¡ã¯è¡æ¶²ããã°ã瀺ããã®
ã§ãè€æ°åã®ããŒã«ã¿ãä»ãæåºå£ïŒããã³æåº
å£ïŒãåããæ¬çºæã®æš¹èçµæç©è£œã®æ¡è¡ããã°
ïŒã¯ããã®åšçžéšãšé«åšæ³¢å ç±ãããã¯ãã®ä»ã®
å ç±æ段ã²ããããŒãã·ãŒã«ãããŠããã該æ¡è¡
ããã°å
éšç©ºéïŒã«é£éããæ¬çºæã®æš¹èçµæç©
補ã®æ¡è¡ããŠãŒãïŒãé£çµãããŠããããã®æ¡è¡
ããã°ã®å
éšç©ºéã«ã¯ãæååºå€ãšããŠACDâ
液ïŒäŸãã°ã氎溶液100mläžã«ã¯ãšã³é
žãããª
ãŠã 2.20ïœãã¯ãšã³é
ž0.80ïœããã³ãããŠç³2.20
ïœå«æïŒãCPD液ïŒäŸãã°ã氎溶液100mläžã«ã¯
ãšã³é
ž0.327ïœãã¯ãšã³é
žãããªãŠã 2.63ïœããª
ã³é
žäºæ°ŽçŽ ãããªãŠã 0.251ïœãããã¹ãããŒã¹
2.32ïœå«æïŒçãåçŽãããŠããããŸããåèšæ¡
è¡ããŠãŒãïŒã®å
端ã«ã¯æ¡è¡éïŒãåä»ããããŠ
ããããã®æ¡è¡éã«ã¯ãã€ããïŒãåä»ããã
ãã
ãŸããåèšæ¡è¡ããã°ïŒã®ä»ã«åããã°ãé£çµ
ããå Žåã«ã¯ãããŒã«ã¿ãä»ãæåºå£ïŒãåãã
æ¬çºæã®æš¹èçµæç©è£œãšåæ§ã«åšçžéšïŒïŒãããŒ
ãã·ãŒã«ããããã€ãã®å
éšç©ºéïŒïŒã«é£éãã
æ¬çºæã®æš¹èçµæç©è£œã®ããŠãŒãïŒïŒãåãã第
ïŒã®åããã°ïŒïŒãåå²ç®¡ïŒïŒãä»ããŠæ¡è¡ãã
ã°ïŒã®é£çµçšæåºå£ïŒã«ãå
端ã®é£çµéïŒïŒã«ã
ãé£çµãããé£çµããŠãŒãïŒïŒãšé£çµãããããŸ
ããããŒã«ã¿ãä»ãæåºå£ïŒïŒãåããã€åšçžéš
ïŒïŒãé«åšæ³¢ã·ãŒã«ããããã®å
éšç©ºéïŒïŒã«é£
éããæ¬çºæã®æš¹èçµæç©è£œã®é£çµããŠãŒãïŒïŒ
ãåããåããã°ïŒïŒã®åèšé£çµããŠãŒãïŒïŒã
åå²ç®¡ïŒïŒãä»ããŠé£çµããŠãŒãïŒïŒïŒïŒïŒãšé£
çµãããã
以äžã¯ãè¡æ¶²ããã°ãäŸã«ãšã€ãŠèª¬æãããã
ãã®ä»ã®è¡æ¶²ä¿å容åšçã«ã€ããŠãåæ§ã«äœ¿çšã§
ããã
ã€ãã«ãå®æœäŸãæããŠæ¬çºæãããã«è©³çŽ°ã«
説æããã
å®æœäŸ ïŒãïŒ
第ïŒè¡šã«ç€ºãå²åã§ã¹ãã¬ã³âãã¿ãžãšã³å
±é
åäœïŒååé75000ïŒã«å¡©åããã«ãã°ã©ããé
åããŠåŸãããã°ã©ããå
±éåäœ100éééšã«å¯Ÿ
ããŠããšããã·å倧è±æ²¹ïŒïŒ¯â130PïŒïŒéééš
ããã³CaâZnç³»å®å®å€ïŒããŒã¯ 593ïŒïŒéééš
ãé
åããŠãªãæš¹èçµæç©ãæŒåºæ圢ããŠ0.4mm
åã®ã·ãŒããåŸãããã®ã·ãŒãã¯éæã§ã溶è¡æ¯
æ§è©Šéšããã³çŽ°èæ¯æ§è©Šéšçµæã¯å¯Ÿç
§æ¶²ãšåæ§ã§
ãã€ãŠã溶è¡æ§ããã³çŽ°èæ¯æ§ã¯ç€ºããªãã€ãã
ãŸããçé
žã¬ã¹ééæ§ãè©Šéšãããšããã第ïŒè¡š
ã®ãšããã§ãã€ãããªãã§ããå®æœäŸïŒãïŒã®ã
ã®ã¯ãæ¯èŒäŸïŒã®ãã®ãããæã«åªããçé
žã¬ã¹
ééæ§ã瀺ããã
æ¯èŒäŸ ïŒ
å¹³åéå床1300ã®ããªå¡©åããã«100éééšã«
察ããŠãšããã·å倧è±æ²¹ïŒïŒ¯â130PïŒïŒéééšã
CaâZnç³»å®å®å€ïŒéééšããã³DOP 25éééš
ãé
åããŠåŸãããå¡©åããã«æš¹èçµæç©ãæŒåº
æ圢ããŠ0.4mmåã®ã·ãŒããåŸãããã®ã·ãŒãã«
ã€ããŠå®æœäŸïŒãïŒãšåæ§ãªè©Šéšãè¡ãªã€ããšã
ãã第ïŒè¡šã®ãšããã§ãã€ãã
æ¯èŒäŸ ïŒ
å¹³åéå床1300ã®ããªå¡©åããã«100éééšã«
察ããŠå®æœäŸïŒãïŒã§äœ¿çšããã¹ãã¬ã³âãã¿ãž
ãšã³å
±éåäœãããããå®æœäŸïŒãïŒãšåæ§ãªå²
åã§é
åãããã®é
åç©100éééšã«å¯ŸããŠãšã
ãã·å倧è±æ²¹ããã³CaâZnç³»å®å®å€ãåæ§ãªå²
åã§é
åããŠ0.4mmåã®ã·ãŒããåŸãããã®ã·ãŒ
ãã¯æ©æ¢°ç匷床ã匱ããå®çšã«é©ããªãã€ãã
å®æœäŸ ïŒã10
第ïŒè¡šã«ç€ºãå²åã§ã¹ãã¬ã³âãã¿ãžãšã³å
±é
åäœïŒååé160000ïŒã«å¡©åããã«ãã°ã©ããé
åããŠåŸãããã°ã©ããå
±éåäœ100éééšã«å¯Ÿ
ããŠããšããã·å倧è±æ²¹ïŒïŒ¯â130PïŒïŒéééšã
CaâZnç³»å®å®å€ïŒããŒã¯ 593ïŒïŒéééšããã³
ã¹ãã¬ã³âé
¢é
žããã«âã±ãã³å
±éåäœïŒãšã«ã
ã〠742ïŒ60éééšãé
åããŠãªãæš¹èçµæç©
ãæŒåºæ圢ããŠ0.4mmåã®ã·ãŒããåŸãããã®ã·
ãŒãã¯éæãã€æè»ã§ã溶è¡æ¯æ§è©Šéšããã³çŽ°è
æ¯æ§è©Šéšçµæã¯å¯Ÿç
§æ¶²ãšåçã§ãã€ãŠã溶è¡æ§ã
ãã³çŽ°èæ¯æ§ã¯ç€ºãããè¡æ¶²ããã°çšã·ãŒããšã
ãŠå¥œé©ãªãã®ã§ãã€ãããŸããçé
žã¬ã¹ééæ§ã
è©Šéšãããšããã第ïŒè¡šã®ãšãã§ãã€ãããªãã§
ããå®æœäŸïŒã10ã®ãã®ã¯ãæ¯èŒäŸïŒã®ãã®ãã
ç¹ã«åªããçé
žã¬ã¹ééæ§ã瀺ããã
æ¯èŒäŸ ïŒ
æ¯èŒäŸïŒã«ãããŠDOPã®éã50éééšã«å¢å
ãã以å€ã¯åæ§ã«é
åããŠã·ãŒããåŸãããã®ã·
ãŒãã«ã€ããŠå®æœäŸïŒã10ãšåæ§ãªè©Šéšãè¡ãªã€
ããšããã第ïŒè¡šã®ãšããã§ãã€ããDETAILED DESCRIPTION OF THE INVENTION BACKGROUND OF THE INVENTION Technical Field The present invention relates to a novel resin composition for blood storage containers. Specifically, the present invention relates to a vinyl chloride-based graft copolymer composition for blood storage containers that has good flexibility and heat resistance, is capable of high-frequency welding, and has excellent gas permeability. Prior Art As is well known, blood has a self-protective effect, and when blood comes into contact with a different interface other than the inner wall of a blood vessel, platelets adhere to the different interface, aggregation, and gelation of plasma, that is, formation of crosslinked fibrin. Formation occurs.
In conventional blood bags, platelets in the blood aggregate to the plastic interface that is the base material of the blood bag, and 6 hours after blood collection, the platelet aggregation ability decreases to about 60% of the time when blood was collected, and after another 24 hours, the platelet aggregation ability decreases to about 60%. It drops to 40%. On the other hand, from the point of view of the effective use of current platelet preparations, it is necessary to develop storage containers made of plastic that can store blood for longer periods of time, storage containers made of so-called blood-compatible plastic, or local medical devices. desired. Currently, plastic containers and other medical devices made of soft vinyl chloride resin are widely used due to their good processability, flexibility, transparency, low water vapor permeability, heat resistance, etc. ing. These soft vinyl chloride resins contain phthalate esters such as di-2-ethylhexyl phthalate (hereinafter referred to as DOP) as plasticizers.
Contains 60%. However, since phthalate esters have a high migration property, it is known that when a blood storage container is made from the above-mentioned soft vinyl chloride resin, the phthalate esters are eluted into blood plasma. For this reason, it has been reported that when phthalate esters dissolve into plasma containing platelet concentrates, they also reduce the aggregation ability, which is a function of platelets. [Japanese Journal of Blood Transfusion 28 , 282 (1982)]. In addition, the soft vinyl chloride resin containing the phthalate ester plasticizer has insufficient gas permeability, and the shelf life of blood bags made using this resin is usually only 6 hours, which is a short period of time. do not have. In other words, soft vinyl chloride resin has a carbon dioxide gas permeability coefficient of approximately 2.0Ã10 3 mlã»mm/m 2ã»atmã»day,
In the blood bag using this, the expiration date of the platelet plasma concentrate was 6 hours. However, this permeability coefficient is 2.5Ã10 3 to 9.0Ã10 3 mlã»mm/m 2ã»atmã»day
More preferably 3.0Ã10 3 to 8.0Ã10 3 mlmm/m 2 .
By using atm-day, the shelf life of platelets was improved, and a pH of 6 or higher, which is considered to be able to effectively preserve platelets, was maintained for more than 72 hours. 2.5
If it is below, the CO 2 concentration generated by platelet metabolism will increase and the PH will decrease, making it impossible to expect long-term preservation of platelets. Also, if it is larger than 9.0,
Platelet metabolism is overactivated and platelet function is likely to be impaired in a short period of time. Note that by keeping the permeability coefficient within the above range, the preservation stability of other blood cells can also be improved. Therefore, if the amount of the plasticizer is increased, gas permeability will be improved, but if the amount is increased, practical mechanical strength will be lost. Therefore, the gas permeability that allows long-term storage of blood cells such as platelets, i.e. 2.5Ã10 3 to 9.0
It is difficult to obtain Ã10 3 mlã»mm/m 2ã»atmã»day. On the other hand, polyester plasticizers are used as non-migratory plasticizers. Since this polyester plasticizer is generally composed mainly of fatty acid ester, it is well known that it is inferior to phthalate esters having a phenyl group as a skeleton in terms of water resistance, hydrolysis resistance, etc. On the other hand, as a blood bag material with relatively good gas permeability, 10 to 40% by weight of polypropylene and
A resin composition consisting of a blend with 40 to 85% by weight of a thermoplastic elastomer is known (Japanese Patent Application Laid-open No.
No. 55-60464), such polyolefin resins have poor adhesive properties, so high frequency fusion is difficult during secondary processing, and molding methods are limited. Additionally, it lacks the flexibility that occurs when soft polyvinyl chloride is used. OBJECT OF THE INVENTION Accordingly, an object of the present invention is to provide a novel resin composition for blood storage containers. Another object of the present invention is to provide a vinyl chloride-based graft copolymer composition for blood storage containers that has good flexibility and heat resistance, is capable of high-frequency welding, and has excellent gas permeability. These objectives are such that the amount of styrene-butadiene copolymer and/or its derivative is 20 to 100 parts by weight of the vinyl chloride portion obtained by reacting the styrene-butadiene copolymer and/or its derivative with vinyl chloride. This is achieved by a resin composition for blood storage containers comprising a graft copolymer and a stabilizer in a proportion of 200 parts by weight. The present invention also provides a resin composition for a blood storage container, in which the styrene-butadiene copolymer and/or its derivative portion is 30 to 120 parts by weight based on 100 parts by weight of the vinyl chloride portion. Furthermore, the present invention is a resin composition in which the derivative of the styrene-butadiene copolymer is an epoxidized product, a halide, or a maleated product of the styrene-butadiene copolymer. Also,
The present invention is a resin composition in which the stabilizer is contained in an amount of 0.05 to 5 parts by weight based on 100 parts by weight of the graft copolymer. DETAILED DESCRIPTION OF THE INVENTION The graft copolymer used in the present invention is a new compound, which is obtained by reacting a styrene-butadiene copolymer and/or a derivative thereof with vinyl chloride. The amount of the graft copolymer and/or its derivative portion is from 20 to 200 parts by weight, preferably from 30 to 120 parts by weight. This is because if the amount of the copolymer or its derivative is less than 20 parts by weight, the graft copolymer will have low flexibility, while if it exceeds 200 parts by weight, the mechanical strength will decrease and high frequency fusion will become difficult. It is from. Such a graft copolymer can be produced, for example, by charging vinyl chloride and a styrene-butadiene copolymer or a derivative thereof into a reactor in the above-mentioned proportions, and then subjecting the vinyl chloride to suspension polymerization in the presence of a radical polymerization catalyst. can get. The graft copolymer thus obtained is purified by washing with water or alcohol, if necessary. The styrene-butadiene copolymer used is
The molar ratio of styrene to butadiene is 1:1 to 1:
10, preferably a 1:2 to 1:6 random or block copolymer, the molecular weight of which is 50,000 to 50,000.
200,000, preferably 70,000 to 190,000. Examples include CALIFLEX TR-110 (Ciel Chemical Co., Ltd.), CALIFLEX TR-1107 (Ciel Chemical Co., Ltd.), Solprene (Asahi Kasei Co., Ltd., Philips Co., Ltd.), Tuffprene (Asahi Kasei Co., Ltd.), Clayton G (Ciel Chemical Co., Ltd.), etc. be. Examples of derivatives thereof include epoxides, halides, and maleates of the styrene-butadiene copolymer. Stabilizers blended into the resin composition of the present invention include metals such as calcium and zinc, stearic acid, lauric acid, ricinoleic acid, naphthenic acid,
There are metal soaps with fatty acids such as 2-ethylhexoic acid, and one or more of these are added to 100 parts by weight of the graft copolymer.
It is blended in an amount of 0.05 to 5 parts by weight, preferably 0.1 to 3 parts by weight. In addition to the above-mentioned stabilizers, epoxidized vegetable oils such as epoxidized soybean oil and epoxidized linseed oil may also be used as stabilizing aids, such as 30 parts by weight or less, preferably 5 to 20 parts by weight, per 100 parts by weight of the graft copolymer. Parts by weight can be blended. Furthermore, in the resin composition of the present invention, a polymer plasticizer can also be blended. Examples of polymeric plasticizers include ethylene copolymers, such as ethylene-
Vinyl acetate-ketone copolymers [e.g. Elvaloy 742.
Co., Ltd.], polyesters such as polycaprolactone-g-(polystyrene), polyε-caprolactone [e.g. PCL 300, PCL 700 (and above, Union
Carbide) polyester (e.g. Nuoplaz)
6187 (manufactured by Tenneco Chemicals), Paraplex G-
25, Paraplex G-54 (manufactured by Rohm & Haas), Admex 761 (manufactured by Ashland Chemicals), etc.]
etc. Among these, the above-mentioned ethylene copolymer (eg, Elvaloy 742) exhibits particularly excellent effects. These polymeric plasticizers are blended in an amount of 150 parts by weight or less, preferably 10 to 90 parts by weight, based on 100 parts by weight of the graft copolymer. Furthermore, lubricants and other additives can also be used as long as they do not exhibit toxicity. The resin composition according to the present invention can be molded using commonly used press molding machines, extrusion molding machines, injection molding machines, blow molding machines, inflation molding machines, calendar molding machines, and the like. A blood storage container can be obtained by assembling and processing these molded products using a high frequency fusion machine or the like. The resin composition obtained in this way has good transparency and flexibility, good heat resistance, allows high frequency fusion, and has a carbon dioxide permeability coefficient of 2.5 Ã 10 3 to 9.0.
Ã10 3 mlã»mm/m 2ã»atmã»day (30â) preferably
3.0Ã10 3 ~8.0Ã10 3 mlã»mm/m 2ã»atmã»day (30â)
It is. Next, a case in which a blood collection bag is manufactured using the resin composition of the present invention will be described with reference to the drawings. That is, the blood sample indicates a blood bag, and the blood collection bag 3 made of the resin composition of the present invention, which is equipped with a plurality of peel-tab-equipped discharge ports 1 and 2, is heated by high-frequency heating or other heating. A blood collection tube 6 made of the resin composition of the present invention is connected to the blood collection bag, which is heat-sealed and communicates with the internal space 5 of the blood collection bag. The internal space of this blood collection bag contains ACD-1 as an anticoagulant.
Solution A (e.g. 2.20 g of sodium citrate, 0.80 g of citric acid and 2.20 g of glucose in 100 ml of aqueous solution)
g), CPD solution (e.g. 0.327 g of citric acid, 2.63 g of sodium citrate, 0.251 g of sodium dihydrogen phosphate, dextrose in 100 ml of aqueous solution)
Contains 2.32g), etc. Further, a blood sampling needle 7 is attached to the tip of the blood sampling tube 6. A cap 8 is attached to this blood collection needle. In addition, when connecting a child bag in addition to the blood collection bag 3, the peripheral part 10 is heat-sealed and the internal space 11 is heat-sealed like the resin composition bag of the present invention equipped with a peel tab-equipped outlet 9. A first child bag 13 having a communicating tube 12 made of the resin composition of the present invention is connected to the connecting outlet 2 of the blood collection bag 3 via a branch pipe 14 by a connecting needle 15 at the tip of the connecting tube. 16. Further, a connecting tube 21 made of the resin composition of the present invention is provided with a discharge port 17 with a peel tab, has a peripheral edge 18 sealed with high frequency, and communicates with the internal space 19.
The connecting tube 21 of the child bag 22 is connected to the connecting tubes 12 and 16 via the branch pipe 14. The above was explained using blood bag as an example,
Other blood storage containers can also be used in the same manner. Next, the present invention will be explained in more detail by giving Examples. Examples 1 to 5 Epoxidized soybean oil (O -130P) and 1 part by weight of a Ca-Zn stabilizer (Mark 593) was extruded to 0.4 mm.
A thick sheet was obtained. The sheet was transparent and the hemolytic and cytotoxicity test results were similar to the control solution, showing no hemolytic or cytotoxic properties.
In addition, carbon dioxide permeability was tested and the results were as shown in Table 1. Among them, those of Examples 2 to 5 sometimes showed better carbon dioxide permeability than that of Comparative Example 1. Comparative Example 1 5 parts by weight of epoxidized soybean oil (O-130P) per 100 parts by weight of polyvinyl chloride with an average degree of polymerization of 1300,
A vinyl chloride resin composition obtained by blending 1 part by weight of a Ca-Zn stabilizer and 25 parts by weight of DOP was extrusion molded to obtain a sheet with a thickness of 0.4 mm. When this sheet was subjected to the same tests as in Examples 1 to 5, the results were as shown in Table 1. Comparative Example 2 The styrene-butadiene copolymers used in Examples 1 to 5 were blended in the same proportions as in Examples 1 to 5 to 100 parts by weight of polyvinyl chloride having an average degree of polymerization of 1300, and this mixture Epoxidized soybean oil and Ca--Zn stabilizer were mixed in the same proportions to parts by weight to obtain a sheet with a thickness of 0.4 mm. This sheet had low mechanical strength and was not suitable for practical use. Examples 6 to 10 Epoxidized soybean oil (O -130P) 5 parts by weight,
A resin composition containing 1 part by weight of Ca-Zn stabilizer (Mark 593) and 60 parts by weight of styrene-vinyl acetate-ketone copolymer (Elvaloy 742) was extruded to obtain a 0.4 mm thick sheet. Ta. This sheet was transparent and flexible, the hemolytic toxicity test and cytotoxicity test results were comparable to the control solution, and it did not exhibit hemolytic or cytotoxic properties, making it suitable as a sheet for blood bags. Further, when carbon dioxide gas permeability was tested, the results were as shown in Table 2. Among them, those of Examples 7 to 10 showed particularly superior carbon dioxide gas permeability than that of Comparative Example 3. Comparative Example 3 A sheet was obtained by blending in the same manner as in Comparative Example 1 except that the amount of DOP was increased to 50 parts by weight. When this sheet was subjected to the same tests as in Examples 6 to 10, the results were as shown in Table 2.
ãè¡šããtableã
ãè¡šã
å®æœäŸ 11
æ¬çºæã«ããæš¹èçµæç©ã®ã¬ã¹ééæ§åäžå¹æ
ãã¿ãããã«ãå®æœäŸïŒã®æš¹èçµæç©ãšã¹ãã¬ã³
âãã¿ãžãšã³å
±éåäœãšãåäžæ¯çãšãªããã
ã«ãããªå¡©åããã«ãšã¹ãã¬ã³âãã¿ãžãšã³å
±é
åäœãšãããã©ããããã©ã³äžã§æº¶è§£æ··åããã¡
ã¿ããŒã«ã§åæ²æŸ±ãè¡ãªãã第ïŒè¡šã«ç€ºãæ¯çã§
ãšããã·å倧è±æ²¹ãCaâZnç³»å®å®å€ããã³ãšã«
ãã〠742ãé
åããŠ0.4mmåã®ã·ãŒããäœè£œ
ããçé
žã¬ã¹ééä¿æ°ã枬å®ãããšããã第ïŒè¡š
ã®ãšããã§ãã€ãã[Table] Example 11 In order to examine the effect of improving gas permeability of the resin composition according to the present invention, polyvinyl chloride and polyvinyl chloride were mixed so that the resin composition of Example 9 and the styrene-butadiene copolymer were in the same ratio. Styrene-butadiene copolymer was dissolved and mixed in tetrahydrofuran, reprecipitated with methanol, and epoxidized soybean oil, Ca-Zn stabilizer, and Elvaloy 742 were blended in the ratio shown in Table 3, and the mixture was mixed to a thickness of 0.4 mm. A sheet was prepared and the carbon dioxide permeability coefficient was measured, and the results were as shown in Table 3.
ãè¡šã
å®æœäŸ 12
å®æœäŸïŒã®ã·ãŒããšãæ¯èŒäŸïŒã®ã·ãŒãã«ã€ã
ãŠãã·ãŒãè¡šé¢ã®è¡å°æ¿ã®ä»çæ°ããã³åœ¢æ
ã®å
é¢ã枬å®ãããšããã第ïŒè¡šã®ãšããã§ãã€ãã
第ïŒè¡š
å®æœäŸïŒ æ¯èŒäŸïŒ
ç·ä»çæ° 157 257
ç·ä»çæ°äžã®åã®æ° 66 113
åã®å²åïŒïŒ
ïŒ 42 44
å®éšæ³
è©Šæè¡šé¢ã«9.5äžåïŒmm3ã®è¡å°æ¿æµ®é液ã滎äž
ãã30åéæŸçœ®åŸã®è¡å°æ¿ã®ä»çæ°ããã³ä»çè¡
å°æ¿ã®åœ¢æ
å€åã芳å¯ããããªããåé¡è©äŸ¡ã®ã
ã¡ãåãšã¯ãè¡å°æ¿ãæ¡åŒµããŠããŠå¹³æ¿äžã«ãª
ã€ãŠãããã®ã§ããã
å®æœäŸ 13
å®æœäŸïŒã®æš¹èçµæç©ãšæ¯èŒäŸïŒã®æš¹èçµæç©
ãšã§ããããåã0.4mmã®ã·ãŒããäœè£œãããã
ã«é«åšæ³¢èçããŠããã°ãäœè£œããããã®ããã°
ã«ACDâ液ãä¿å液ãšããŠãæ¿çž®è¡å°æ¿è¡æŒ¿
ãïŒmlå
¥ãã22âã§72æéä¿åããå Žåã®è©²ã·ãŒ
ãã®çé
žã¬ã¹ééæ§ãšPHå€åãšã芳å¯ãããšã
ãã第ïŒè¡šã®çµæãåŸãã[Table] Example 12 Regarding the sheet of Example 8 and the sheet of Comparative Example 3, the number of platelets attached to the sheet surface and the separation of their morphology were measured, and the results were as shown in Table 4. Table 4 Example 8 Comparative Example 3 Total number of adherents 157 257 Number of molds in total number of adherents 66 113 Percentage of molds (%) 42 44 Experimental method 95,000/mm 3 platelet suspension was dropped onto the sample surface. The number of attached platelets and morphological changes of attached platelets were observed after leaving for 30 minutes. In addition, in the classification evaluation, the platelet type is one in which the platelets are expanded and formed on a flat plate. Example 13 Sheets each having a thickness of 0.4 mm were prepared from the resin composition of Example 8 and the resin composition of Comparative Example 3, and then high frequency welded to form bags. 3 ml of concentrated platelet plasma was added to this bag using ACD-A solution as a storage solution, and when the sheet was stored at 22°C for 72 hours, the carbon dioxide gas permeability and PH changes of the sheet were observed, and the results shown in Table 5 were obtained. Obtained.
ãè¡šã
è¡å°æ¿ä¿åäžã®PHã®ç¶æã¯ã茞è¡æ¶²ã®è¡å°æ¿ç
åçã«éèŠãªæå³ããã€ãŠãããæ¬çºæã®å®æœäŸ
ïŒã®ããã«ããŠçé
žã¬ã¹ééæ§ã®é«ãããã°ã§ä¿
åããå ŽåãPHã®äœäžãæ¯èŒäŸïŒã®ãã®ããå°ã
ããè¡å°æ¿ä¿åäžã®æ©èœç¶æãããããšã¯æçœã§
ããã
çºæã®å
·äœçå¹æ
以äžè¿°ã¹ãããã«ãæ¬çºæã«ããè¡æ¶²ä¿å容åš
çšæš¹èçµæç©ã¯ãã¹ãã¬ã³âãã¿ãžãšã³å
±éåäœ
ããã³ïŒãŸãã¯ãã®èªå°äœã«å¡©åããã«ãåå¿ã
ããŠåŸãããå¡©åããã«éšå100éééšã«å¯ŸããŠ
ã¹ãã¬ã³âãã¿ãžãšã³å
±éåäœããã³ïŒãŸãã¯ã
ã®èªå°äœéšåã20ã200éééšã奜ãŸããã¯ïŒã
120éééšã®å²åã§ããã°ã©ããå
±éåäœããã³
å®å®å€ãããªããã®ã§ãããããæè»æ§ããã³è
ç±æ§ãè¯å¥œã§ãã€é«åšæ³¢èçãå¯èœã§ãããã«æ°
äœééæ§ãç¹ã«çé
žã¬ã¹ééæ§ã«åªããŠããããŸ
ããå¡©åããã«éšå100éééšã«å¯ŸããŠã¹ãã¬ã³
âãã¿ãžãšã³å
±éåäœããã³ïŒãŸãã¯ãã®èªå°äœ
éšåã20ã200éééšã奜ãŸããã¯30ã120éééš
ã§ããã®ã§ãç¹ã«çé
žã¬ã¹ééæ§ãè¯å¥œã§ããã
ããã«ãæ¬çºæã«ããæš¹èçµæç©ã¯ã溶è¡æ¯æ§ãª
ãã³ã«çŽ°èæ¯æ§ããªãããã€è¡å°æ¿ä»çããã³åœ¢
æ
å€åãå°ããããããPHå€åãå°ããã®ã§ãè¡
液ããã°çã®å»ççšå
·çšææãšããŠæ¥µããŠæçšã§
ããããŸããéèçã®ä»£è¬ãè¡ãªãå
容ç©ã®å
è£
ææãšããŠæçšã§ããã[Table] Maintaining the PH during platelet storage has an important meaning for the platelet survival rate of transfused blood. It is clear that the decrease in the value was smaller than that of Comparative Example 3, and that the function was maintained well during platelet storage. Specific Effects of the Invention As described above, the resin composition for blood storage containers according to the present invention is characterized in that 100 parts by weight of vinyl chloride is obtained by reacting vinyl chloride with a styrene-butadiene copolymer and/or a derivative thereof. 20 to 200 parts by weight of the styrene-butadiene copolymer and/or its derivative, preferably 0 to 200 parts by weight.
Since it is composed of 120 parts by weight of a graft copolymer and a stabilizer, it has good flexibility and heat resistance, is capable of high frequency welding, and has excellent gas permeability, especially carbon dioxide gas permeability. There is. In addition, since the styrene-butadiene copolymer and/or its derivative portion is 20 to 200 parts by weight, preferably 30 to 120 parts by weight, per 100 parts by weight of the vinyl chloride portion, carbon dioxide gas permeability is particularly good. .
Further, the resin composition according to the present invention is free of hemolytic toxicity and cytotoxicity, has low platelet adhesion and morphological change, and has low PH change, and is therefore extremely useful as a material for medical devices such as blood bags. It is also useful as a packaging material for contents that undergo metabolism, such as vegetables.
å³é¢ã¯ãæ¬çºæã«ããæš¹èçµæç©ãçšããå»ç
çšå
·ã®äžäŸã瀺ãæ£é¢å³ã§ããã
ïŒâŠâŠè¡æ¶²ããã°ãïŒïŒïŒïŒïŒâŠâŠåããã°ã
ïŒïŒïŒïŒïŒïŒïŒâŠâŠããŠãŒãã
The drawing is a front view showing an example of a medical device using the resin composition according to the present invention. 3...Blood bug, 13,22...Child bug,
6, 16, 21...Tube.
Claims (1)
ã¯ãã®èªå°äœã«å¡©åããã«ãåå¿ãããŠåŸããã
å¡©åããã«éšå100éééšã«å¯ŸããŠã¹ãã¬ã³âã
ã¿ãžãšã³éåäœããã³ïŒãŸãã¯ãã®èªå°äœéšåã
20ã200éééšã®å²åã§ããã°ã©ããå ±éåäœã
ãã³å®å®å€ãããªãè¡æ¶²ä¿å容åšçšæš¹èçµæç©ã ïŒ ã¹ãã¬ã³âãã¿ãžãšã³å ±éåäœã®èªå°äœãã¹
ãã¬ã³âãã¿ãžãšã³å ±éåäœã®ãšããã·åç©ãã
ãã²ã³åç©ãŸãã¯ãã¬ã€ã³åç©ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé ã«èšèŒã®è¡æ¶²ä¿å容åšçšæš¹èçµæç©ã ïŒ ã°ã©ããå ±éåäœ100éééšã«å¯ŸããŠå®å®å€
ã0.05ãïŒéééšé åãããŠãªãç¹èš±è«æ±ã®ç¯å²
第ïŒé ãŸãã¯ç¬¬ïŒé ã«èšèŒã®è¡æ¶²ä¿å容åšçšæš¹è
çµæç©ã ïŒ çé žã¬ã¹ééä¿æ°ã2.5Ã103ã9.0Ã103mlã»
mmïŒm2ã»atmã»dayã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ãªãã第ïŒé ã®ããããäžã€ã«èšèŒã®è¡æ¶²ä¿å容
åšçšæš¹èçµæç©ã[Scope of Claims] 1. The styrene-butadiene copolymer and/or its derivative portion is based on 100 parts by weight of the vinyl chloride portion obtained by reacting the styrene-butadiene copolymer and/or its derivative with vinyl chloride.
A resin composition for a blood storage container comprising a graft copolymer and a stabilizer in a proportion of 20 to 200 parts by weight. 2. The resin composition for a blood storage container according to claim 1, wherein the derivative of the styrene-butadiene copolymer is an epoxidized product, a halide, or a maleated product of the styrene-butadiene copolymer. 3. The resin composition for a blood storage container according to claim 1 or 2, which contains 0.05 to 5 parts by weight of a stabilizer based on 100 parts by weight of the graft copolymer. 4 Carbon dioxide permeability coefficient is 2.5Ã10 3 to 9.0Ã10 3 mlã»
The resin composition for a blood storage container according to any one of claims 1 to 3, which has a particle size of mm/m 2 ·atm ·day.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58062239A JPS59189153A (en) | 1983-04-11 | 1983-04-11 | Resin composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58062239A JPS59189153A (en) | 1983-04-11 | 1983-04-11 | Resin composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59189153A JPS59189153A (en) | 1984-10-26 |
JPH0356739B2 true JPH0356739B2 (en) | 1991-08-29 |
Family
ID=13194396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58062239A Granted JPS59189153A (en) | 1983-04-11 | 1983-04-11 | Resin composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59189153A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7357940B2 (en) * | 2003-07-31 | 2008-04-15 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices containing graft copolymer for controlled delivery of therapeutic agents |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL57233A (en) * | 1978-06-29 | 1981-12-31 | Stauffer Chemical Co | Homogenizer process for forming emulsion/suspension polymers |
-
1983
- 1983-04-11 JP JP58062239A patent/JPS59189153A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59189153A (en) | 1984-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5026347A (en) | Plastic composition with anti-hemolytic effect | |
US5167657A (en) | Plastic composition with anti-hemolytic effect | |
US5100401A (en) | Plastic composition with anti-hemolytic effect | |
EP0230744B1 (en) | Propylene polymer composition | |
JPH0136384B2 (en) | ||
EP0340305B1 (en) | Hemolysis inhibitor and plasticizer | |
WO1993014810A2 (en) | Material for medical grade products and products made therefrom | |
EP0778030B1 (en) | Container for medical use | |
US5248531A (en) | Hemolysis depressant and plasticizer | |
US4329992A (en) | Medical apparatus for parenteral liquids | |
AU623071B2 (en) | Hemolysis inhibitor and medical resin composition, medical implement, and blood-preserving fluid containing the same | |
JPH0356739B2 (en) | ||
EP0409155A2 (en) | Bag for storage of platelets and multiple bag system containing the bag | |
JPS6158191B2 (en) | ||
EP0108955B1 (en) | Medical articles | |
JPH0149303B2 (en) | ||
EP0330151A2 (en) | Bag for the storage of blood platelets | |
JP2007130503A (en) | Blood component storage container and blood component storage device connected with blood component storage container | |
JPS6158192B2 (en) | ||
JPS5967960A (en) | Blood preserving container | |
JPH0422363A (en) | Bag for preserving platelet and composite bag using the same | |
JPH02211160A (en) | Blood bag | |
JPH04210061A (en) | Platelet preserving container | |
JPH01104264A (en) | Medical soft resin composition and medical utensil | |
JPH0611287B2 (en) | Platelet storage bag and composite bag using the same |